Compare · SNN vs XPEL
SNN vs XPEL
Side-by-side comparison of Smith & Nephew SNATS Inc. (SNN) and XPEL Inc. (XPEL): market cap, price performance, sector, and recent activity on the wire.
Summary
- SNN operates in Health Care, while XPEL operates in Industrials - the two are in different parts of the market.
- SNN is the larger of the two at $13.00B, about 10.9x XPEL ($1.19B).
- Over the past year, SNN is up 1.5% and XPEL is up 25.9% - XPEL leads by 24.4 points.
- SNN has been more active in the news (7 items in the past 4 weeks vs 2 for XPEL).
- SNN has more recent analyst coverage (23 ratings vs 3 for XPEL).
- Company
- Smith & Nephew SNATS Inc.
- XPEL Inc.
- Price
- $30.60-2.55%
- $43.24-5.18%
- Market cap
- $13.00B
- $1.19B
- 1M return
- +0.36%
- -3.54%
- 1Y return
- +1.48%
- +25.92%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 2
- Recent ratings
- 23
- 3
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
XPEL Inc.
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Latest SNN
- Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
- New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
- New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
Latest XPEL
- Senior Vice President/CFO Wood Barry covered exercise/tax liability with 391 shares, was granted 968 shares and converted options into 637 shares, increasing direct ownership by 4% to 31,302 units (SEC Form 4)
- President and CEO Pape Ryan converted options into 1,990 shares, covered exercise/tax liability with 1,222 shares and was granted 3,026 shares, increasing direct ownership by 0.35% to 1,087,570 units (SEC Form 4)
- Director Bogart Stacy L converted options into 532 shares, increasing direct ownership by 7% to 8,466 units (SEC Form 4)
- Director Crumly Richard K. converted options into 532 shares, increasing direct ownership by 10% to 5,866 units (SEC Form 4)
- Director Klonne Mike converted options into 532 shares, increasing direct ownership by 14% to 4,248 units (SEC Form 4)
- Director North John F converted options into 532 shares, increasing direct ownership by 5% to 10,275 units (SEC Form 4)
- SEC Form S-8 POS filed by XPEL Inc.
- XPEL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 4 filed by Director Thornton Mark Andrew
- SEC Form 4 filed by Director Crumly Richard K.